Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -162.34% | -144.79% | -147.76% | -117.04% | -70.74% |
| Total Depreciation and Amortization | -27.04% | -23.15% | -19.66% | -17.87% | 38.60% |
| Total Amortization of Deferred Charges | -47.99% | -65.69% | -74.99% | -73.46% | -49.16% |
| Total Other Non-Cash Items | 105.70% | 103.95% | 103.27% | 102.45% | 54.27% |
| Change in Net Operating Assets | -67.45% | -71.88% | -83.45% | -70.63% | 220.02% |
| Cash from Operations | -3.37% | -7.28% | -5.28% | 27.85% | 55.65% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.27% | -67.50% | -76.13% | -60.49% | 290.83% |
| Cash from Investing | 36.85% | 16.10% | 8.06% | 329.67% | 310.37% |
| Total Debt Issued | -18.03% | -10.66% | -13.87% | -31.56% | -26.68% |
| Total Debt Repaid | 24.29% | 21.68% | 28.27% | 30.38% | -52.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.23% | 7.85% | 6.22% | -32.82% | -64.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | 100.00% |